ReviewDiscover oncology2026

Metformin in prostate cancer: a context-dependent antitumour strategy driven by metabolic vulnerability and signalling network.

Lingling Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.